Ypsomed Holding AG

CH

YPSN

Health Care

405 ₽

Current price

Sell
405 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    126 / 236

  • Position in country

    274 / 449

  • Return on Assets, %

    8.4

    1.6

  • Net income margin, %

    14.3

    2.7

  • EBITDA margin, %

    29.6

    10.2

  • Debt to Equity, %

    35.3

    13.9

  • Intangible assets and goodwill, %

    27.4

    2.7

  • Revenue CAGR 3Y, %

    8

    11.3

  • Revenue Y, % chg

    8.9

    0

  • P/E

    71.5

    25.8

  • P/BV

    9

    1.5

  • P/S

    10.1

    2.8

  • EV/S

    10.5

    2.5

  • EV/EBITDA

    33.8

    9

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    9.3

    36.5

  • Forward P/E

    43.8

    18.3

  • Dividend Yield, %

    0.3

    2

  • Forward Dividend Yield, %

    0.9

    0.2

  • Expected dividend per share

    3.7

    0

  • Payout Ratio, %

    24.5

    32.2

  • Dividend Ex Date

    2023-07-03

Get an analytical review of this company

Competitors

Ranks

  • Shenzhen New Industries Biomedical Engineering Co Ltd

    00%

  • EssilorLuxottica SA

    00%

  • Hoya Corp

    00%

  • Alcon AG

    00%

  • ConvaTec Group PLC

    00%

  • Ypsomed Holding AG

    00%

  • Coloplast A/S

    00%

  • Align Technology Inc

    00%

  • Cooper Companies Inc

    00%

  • HLB Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    Switzerland

  • Sector

    Health Care

  • Industry group

    Health Care Equipment & Services

  • Industry

    Health Care Equipment & Supplies

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    5701.1

  • Ticker

    YPHDF.PK

  • ISIN

    CH0019396990

  • IPO date

    2004-09-22

  • Availability on Russian exchanges

    No

  • Reporting for

    2023-11-15

  • Date fact. publication of reports

    2023-09-30

Company Description

Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.